Close

Ira Longini

Professor

Education

Affiliations

Projects

Papers

Dean NE, Gsell PS, Brookmeyer R, De Gruttola V, Donnelly CA, Halloran ME, Jasseh M, Nason M, Riveros X, Watson CH, Henao-Restrepo AM, Longini IM. (2019). Design of vaccine efficacy trials during public health emergencies. Science translational medicine, 11(499)

Longini IM, Røttingen JA, Kieny MP, Edmunds WJ, Henao-Restrepo AM. (2018). Questionable efficacy of the rVSV-ZEBOV Ebola vaccine - Authors' reply. Lancet (London, England), 391(10125)

Yang Y, Meng Y, Halloran ME, Longini IM Jr.. (2018). Dependency of Vaccine Efficacy on Preexposure and Age: A Closer Look at a Tetravalent Dengue Vaccine. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 66(2)

Yang Y, Meng Y, Halloran ME, Longini IM Jr.. (2018). Reply to Aguiar and Stollenwerk. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 66(4)

Hladish TJ, Pearson CAB, Patricia Rojas D, Gomez-Dantes H, Halloran ME, Vazquez-Prokopec GM, Longini IM. (2018). Forecasting the effectiveness of indoor residual spraying for reducing dengue burden. PLoS neglected tropical diseases, 12(6)

Dean NE, Halloran ME, Longini IM. (2018). DESIGN OF VACCINE TRIALS DURING OUTBREAKS WITH AND WITHOUT A DELAYED VACCINATION COMPARATOR. The annals of applied statistics, 12(1)

Kirpich A, Weppelmann TA, Yang Y, Morris JG Jr., Longini IM Jr.. (2017). Controlling cholera in the Ouest Department of Haiti using oral vaccines. PLoS neglected tropical diseases, 11(4)

Dean NE, Halloran ME, Yang Y, Longini IM. (2016). Transmissibility and Pathogenicity of Ebola Virus: A Systematic Review and Meta-analysis of Household Secondary Attack Rate and Asymptomatic Infection. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 62(10)

Rojas DP, Dean NE, Yang Y, Kenah E, Quintero J, Tomasi S, Ramirez EL, Kelly Y, Castro C, Carrasquilla G, Halloran ME, Longini IM. (2016). The epidemiology and transmissibility of Zika virus in Girardot and San Andres island, Colombia, September 2015 to January 2016. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 21(28)

Hladish TJ, Pearson CA, Chao DL, Rojas DP, Recchia GL, Gómez-Dantés H, Halloran ME, Pulliam JR, Longini IM. (2016). Projected Impact of Dengue Vaccination in Yucatán, Mexico. PLoS neglected tropical diseases, 10(5)

Kenah E, Britton T, Halloran ME, Longini IM Jr.. (2016). Molecular Infectious Disease Epidemiology: Survival Analysis and Algorithms Linking Phylogenies to Transmission Trees. PLoS computational biology, 12(4)

Kirpich A, Weppelmann TA, Yang Y, Ali A, Morris JG Jr., Longini IM. (2016). Correction: Cholera Transmission in Ouest Department of Haiti: Dynamic Modeling and the Future of the Epidemic. PLoS neglected tropical diseases, 10(1)

Schwartz LM, Halloran ME, Durbin AP, Longini IM Jr.. (2015). The dengue vaccine pipeline: Implications for the future of dengue control. Vaccine, 33(29)

Kirpich A, Weppelmann TA, Yang Y, Ali A, Morris JG Jr., Longini IM. (2015). Cholera Transmission in Ouest Department of Haiti: Dynamic Modeling and the Future of the Epidemic. PLoS neglected tropical diseases, 9(10)

Longini IM, Egger M, Dean NE, Edmunds WJ, Henao-Restrepo AM, . (2015). Ebola vaccination - Authors' reply. Lancet (London, England), 386(10012)

Yang Y, Zhang Y, Fang L, Halloran ME, Ma M, Liang S, Kenah E, Britton T, Chen E, Hu J, Tang F, Cao W, Feng Z, Longini IM Jr.. (2015). Household transmissibility of avian influenza A (H7N9) virus, China, February to May 2013 and October 2013 to March 2014. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 20(10)

Matrajt L, Britton T, Halloran ME, Longini IM Jr.. (2015). One versus two doses: What is the best use of vaccine in an influenza pandemic?. Epidemics

Halloran ME, Vespignani A, Bharti N, Feldstein LR, Alexander KA, Ferrari M, Shaman J, Drake JM, Porco T, Eisenberg JN, Del Valle SY, Lofgren E, Scarpino SV, Eisenberg MC, Gao D, Hyman JM, Eubank S, Longini IM Jr.. (2014). Ebola: mobility data. Science (New York, N.Y.), 346(6208)

Halloran ME, Longini IM Jr.. (2014). Emerging, evolving, and established infectious diseases and interventions. Science (New York, N.Y.), 345(6202)

Sugimoto JD, Koepke AA, Kenah EE, Halloran ME, Chowdhury F, Khan AI, LaRocque RC, Yang Y, Ryan ET, Qadri F, Calderwood SB, Harris JB, Longini IM Jr.. (2014). Household Transmission of Vibrio cholerae in Bangladesh. PLoS neglected tropical diseases, 8(11)

Matrajt L, Halloran ME, Longini IM Jr.. (2013). Optimal vaccine allocation for the early mitigation of pandemic influenza. PLoS computational biology, 9(3)

Chao DL, Halstead SB, Halloran ME, Longini IM Jr.. (2012). Controlling dengue with vaccines in Thailand. PLoS neglected tropical diseases, 6(10)

Chao DL, Bloom JD, Kochin BF, Antia R, Longini IM Jr.. (2012). The global spread of drug-resistant influenza. Journal of the Royal Society, Interface, 9(69)

Matrajt L, Longini IM Jr.. (2012). Critical immune and vaccination thresholds for determining multiple influenza epidemic waves. Epidemics, 4(1)

Longini IM Jr.. (2012). A theoretic framework to consider the effect of immunizing schoolchildren against influenza: implications for research. Pediatrics

Chao DL, Halloran ME, Longini IM Jr.. (2011). Vaccination strategies for epidemic cholera in Haiti with implications for the developing world. Proceedings of the National Academy of Sciences of the United States of America, 108(17)

Chao DL, Matrajt L, Basta NE, Sugimoto JD, Dean B, Bagwell DA, Oiulfstad B, Halloran ME, Longini IM Jr.. (2011). Planning for the control of pandemic influenza A (H1N1) in Los Angeles County and the United States. American journal of epidemiology, 173(10)

Kenah E, Chao DL, Matrajt L, Halloran ME, Longini IM Jr.. (2011). The global transmission and control of influenza. PLoS One, 6(5)

Chao DL, Halloran ME, Obenchain VJ, Longini IM Jr.. (2010). FluTE, a publicly available stochastic influenza epidemic simulation model. PLoS computational biology, 6(1)

Chao DL, Halloran ME, Longini IM Jr.. (2010). School opening dates predict pandemic influenza A(H1N1) outbreaks in the United States. The Journal of infectious diseases, 202(6)

Matrajt L Jr., Longini IM. (2010). Optimizing vaccine allocation at different points in time during an epidemic. PLoS One, 5(11)

Yang Y, Sugimoto JD, Halloran ME, Basta NE, Chao DL, Matrajt L, Potter G, Kenah E, Longini IM Jr.. (2009). The transmissibility and control of pandemic influenza A (H1N1) virus. Science (New York, N.Y.), 326(5953)

Basta NE, Chao DL, Halloran ME, Matrajt L, Longini IM Jr.. (2009). Strategies for pandemic and seasonal influenza vaccination of schoolchildren in the United States. American journal of epidemiology, 170(6)

Cowling BJ, Ng S, Longini IM Jr.. (2009). A/H1N1 flu pandemic. Antiviral drugs: distinguish treatment from prophylaxis. BMJ (Clinical research ed.)

Yang Y, Halloran ME, Longini IM Jr.. (2009). A Bayesian model for evaluating influenza antiviral efficacy in household studies with asymptomatic infections. Biostatistics (Oxford, England), 10(2)

Abu-Raddad LJ, Longini IM Jr.. (2008). No HIV stage is dominant in driving the HIV epidemic in sub-Saharan Africa. AIDS (London, England), 22(9)

Sander B, Nizam A, Garrison LP Jr., Postma MJ, Halloran ME, Longini IM Jr.. (2008). Economic evaluation of influenza pandemic mitigation strategies in the United States using a stochastic microsimulation transmission model. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 12(2)

Basta NE, Halloran ME, Matrajt L, Longini IM Jr.. (2008). Estimating influenza vaccine efficacy from challenge and community-based study data. American journal of epidemiology, 168(12)

Longini IM Jr., Nizam A, Ali M, Yunus M, Shenvi N, Clemens JD. (2007). Controlling endemic cholera with oral vaccines. PLoS medicine, 4(11)

Yang Y, Halloran ME, Sugimoto JD, Longini IM Jr.. (2007). Detecting human-to-human transmission of avian influenza A (H5N1). Emerging infectious diseases, 13(9)

Longini IM Jr., Halloran ME, Nizam A, Yang Y, Xu S, Burke DS, Cummings DA, Epstein JM. (2007). Containing a large bioterrorist smallpox attack: a computer simulation approach. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 11(2)

Abu-Raddad LJ, Boily MC, Self S, Longini IM Jr.. (2007). Analytic insights into the population level impact of imperfect prophylactic HIV vaccines. Journal of acquired immune deficiency syndromes (1999), 45(4)

Halloran ME, Longini IM Jr.. (2006). Public health. Community studies for vaccinating schoolchildren against influenza. Science (New York, N.Y.), 311(5761)

Longini IM Jr., Halloran ME. (2005). Strategy for distribution of influenza vaccine to high-risk groups and children. American journal of epidemiology, 161(4)

Longini IM Jr., Nizam A, Xu S, Ungchusak K, Hanshaoworakul W, Cummings DA, Halloran ME. (2005). Containing pandemic influenza at the source. Science (New York, N.Y.), 309(5737)

Longini IM Jr., Halloran ME, Nizam A, Yang Y. (2004). Containing pandemic influenza with antiviral agents. American journal of epidemiology, 159(7)

Hill AN, Longini IM Jr.. (2003). The critical vaccination fraction for heterogeneous epidemic models. Mathematical biosciences, 181(1)

Longini IM Jr., Halloran ME, Nizam A. (2002). Model-based estimation of vaccine effects from community vaccine trials. Statistics in medicine, 21(4)

Longini IM Jr., Yunus M, Zaman K, Siddique AK, Sack RB, Nizam A. (2002). Epidemic and endemic cholera trends over a 33-year period in Bangladesh. The Journal of infectious diseases, 186(2)

Halloran ME, Longini IM Jr.. (2001). Using validation sets for outcomes and exposure to infection in vaccine field studies. American journal of epidemiology, 154(5)

Longini IM Jr., Sagatelian K, Rida WN, Halloran ME. (1998). Optimal vaccine trial design when estimating vaccine efficacy for susceptibility and infectiousness from multiple populations. Statistics in medicine, 17(10)

Halloran ME, Struchiner CJ, Longini IM Jr.. (1997). Study designs for evaluating different efficacy and effectiveness aspects of vaccines. American journal of epidemiology, 146(10)

Longini IM Jr., Datta S, Halloran ME. (1996). Measuring vaccine efficacy for both susceptibility to infection and reduction in infectiousness for prophylactic HIV-1 vaccines. Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 13(5)

Longini IM Jr., Halloran ME. (1995). AIDS: modeling epidemic control. Science (New York, N.Y.), 267(5202)

Halloran ME, Haber M, Longini IM Jr.. (1992). Interpretation and estimation of vaccine efficacy under heterogeneity. American journal of epidemiology, 136(3)

Longini IM Jr., Haber MJ, Halloran ME. (1990). [Direct and indirect effects of vaccines: an annotation on the estimation of the vaccine efficacy from outbreaks caused by acute infection agents such as measles]. Boletin medico del Hospital Infantil de Mexico, 47(7)